Vivo Bio Tech Limited (BOM:511509)

Market Cap	693.33M
Revenue (ttm)	461.40M
Net Income (ttm)	69.56M
Shares Out	17.92M
EPS (ttm)	4.16
PE Ratio	9.30
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	43,148
Average Volume	70,407
Open	39.50
Previous Close	40.25
Day's Range	39.15 - 39.99
52-Week Range	31.20 - 56.90
Beta	0.37
RSI	57.28
Earnings Date	May 20, 2025

About Vivo Bio Tech

Vivo Bio Tech Limited provides drug development and discovery services to pharmaceutical and biotech companies worldwide. The company offers services in the areas of in vivo and in vitro toxicity studies, pharmacological investigations, pharmacokinetic and toxic kinetic studies, genotoxicity screening, and analytical services. It also supplies SPF lab animals; breeds and distributes rodent models; and offers custom rodent models, and stem cell products, as well as lab animal diets. In addition, the company provides regulatory and non-regulatory...

• Industry: Commercial Physical and Biological Research
• Founded: 1987
• Employees: 161
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 511509

Financial Performance

In 2023, Vivo Bio Tech's revenue was 454.51 million, a decrease of -12.98% compared to the previous year's 522.30 million. Earnings were 25.26 million, a decrease of -4.64%.